Qian Yuan Baixing, Inc. (QYBX)

[Badfoot]

10% stake or may lead to a possible buyout of MDCX.

The #1 BIOTECH Medical Stock to BUY right now

Backed by a BILLION dollar venture capital group, PMT Advisory, Wall Street's biggest money is behind MDCorp. (MDCX). With deep roots in the under served Asian marketplace, so much success is already anticipated for MDCX as it extends it's reach from Europe into the Asian and Pacific Rim that it is forecast in the future to see what similar well funded start up stocks experienced with institutional buying from biotech-focused hedge fund Baker Bros. Advisors along with two big pharmas, Pfizer (PFE) and Johnson and Johnson (JNJ) who all may also try to buy 10% stakes in private offerings!

"Represents the best Biotech ground floor opportunity for investor's so far in 2017, potentially the best medical stock of 2017, Pfizer, Merck and Roche watch out, there is a new sheriff in town!" Stock Market Rater July 2017